BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26865392)

  • 1. Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study.
    Duran I; Fink MG; Bahl A; Hoefeler H; Mahmood A; Lüftner D; Ghazal H; Wei R; Chung KC; Hechmati G; Green J; Atchison C
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 26865392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health resource utilization associated with skeletal-related events: results from a retrospective European study.
    Body JJ; Pereira J; Sleeboom H; Maniadakis N; Terpos E; Acklin YP; Finek J; Gunther O; Hechmati G; Mossman T; Costa L; Rogowski W; Nahi H; von Moos R
    Eur J Health Econ; 2016 Jul; 17(6):711-21. PubMed ID: 26253584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian health care institution resource utilization resulting from skeletal-related events.
    Habib MJ; Merali T; Mills A; Uon V
    Hosp Pract (1995); 2014 Feb; 42(1):15-22. PubMed ID: 24566592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study.
    Hechmati G; Cure S; Gouépo A; Hoefeler H; Lorusso V; Lüftner D; Duran I; Garzon-Rodriguez C; Ashcroft J; Wei R; Ghelani P; Bahl A
    J Med Econ; 2013; 16(5):691-700. PubMed ID: 23441975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.
    Barlev A; Song X; Ivanov B; Setty V; Chung K
    J Manag Care Pharm; 2010; 16(9):693-702. PubMed ID: 21067255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours.
    Zheng GZ; Chang B; Lin FX; Xie D; Hu QX; Yu GY; Du SX; Li XD
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27430483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care plan.
    Henk HJ; Kaura S
    J Med Econ; 2012; 15(1):175-84. PubMed ID: 22017235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of skeletal complications from bone metastases in six European countries.
    Pereira J; Body JJ; Gunther O; Sleeboom H; Hechmati G; Maniadakis N; Terpos E; Acklin YP; Finek J; von Moos R
    J Med Econ; 2016 Jun; 19(6):611-8. PubMed ID: 26849381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare resource utilisation associated with skeletal-related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study.
    Ashcroft J; Duran I; Hoefeler H; Lorusso V; Lueftner D; Campioni M; Intorcia M; Bahl A
    Eur J Haematol; 2018 May; 100(5):479-487. PubMed ID: 29444353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
    Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
    Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden associated with skeletal-related events in patients with bone metastases secondary to solid tumors in Belgium.
    Body JJ; Chevalier P; Gunther O; Hechmati G; Lamotte M
    J Med Econ; 2013; 16(4):539-46. PubMed ID: 23425250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours.
    Durán I; Garzón C; Sánchez A; García-Carbonero I; Pérez-Gracia JL; Seguí-Palmer MÁ; Wei R; Restovic G; Gasquet JA; Gutiérrez L
    Clin Transl Oncol; 2014 Mar; 16(3):322-9. PubMed ID: 23943561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone metastases in lung cancer].
    Tsuya A; Fukuoka M
    Clin Calcium; 2008 Apr; 18(4):455-9. PubMed ID: 18379026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bisphosphonates in metastatic breast cancer: single institution review at the Dr. H. Bliss Murphy Cancer Centre.
    Murphy L; McCarthy J; McCrate F; Laing K; Powell E; Seal M; Edwards S
    Support Care Cancer; 2013 Jun; 21(6):1557-60. PubMed ID: 23334521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases.
    Hagiwara M; Delea TE; Chung K
    J Med Econ; 2014 Mar; 17(3):223-30. PubMed ID: 24494707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Use Among Metastatic Prostate Cancer Patients With Skeletal-related Events.
    Yaldo A; Wen L; Ogbonnaya A; Valderrama A; Kish J; Eaddy M; Kreilick C; Tangirala K; Shields K
    Clin Ther; 2016 Aug; 38(8):1880-9. PubMed ID: 27478111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.
    Jayasekera J; Onukwugha E; Bikov K; Mullins CD; Seal B; Hussain A
    Pharmacoeconomics; 2014 Feb; 32(2):173-91. PubMed ID: 24435407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational study.
    Lorusso V; Duran I; Garzon-Rodriguez C; Lüftner D; Bahl A; Ashcroft J; Hechmati G; Wei R; Thomas E; Hoefeler H
    Mol Clin Oncol; 2014 Sep; 2(5):701-708. PubMed ID: 25054033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours.
    Carter JA; Joshi AD; Kaura S; Botteman MF
    Pharmacoeconomics; 2012 May; 30(5):373-86. PubMed ID: 22500986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational study.
    Lüftner D; Lorusso V; Duran I; Hechmati G; Garzon-Rodriguez C; Ashcroft J; Bahl A; Ghelani P; Wei R; Thomas E; Hoefeler H
    Springerplus; 2014; 3():328. PubMed ID: 25045611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.